3.63  0.36 (11.01%)		04-10 16:00
Open: 3.27 High: 3.7 Volume: 411,261		Pre. Close: 3.27 Low: 3.27 Market Cap: 18(M)

Short term
Mid term
Targets	6-month :	4.7	1-year :	5.49
Resists	First :	4.03	Second :	4.7
Pivot price	3.35
Supports	First :	3.35	Second :	2.93
MAs	MA(5) :	3.29	MA(20) :	3.44
	MA(100) :	3.58	MA(250) :	5.35
MACD	MACD :	-0.1	Signal :	-0.1
%K %D	K(14,3) :	49.9	D(3) :	33.1
RSI	RSI(14): 55.4
52-week	High :	17.18	Low :	0.89

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ HYPD ] has closed below upper band by 7.8%. Bollinger Bands are 54.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 14 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	3.7 - 3.72	3.72 - 3.73
Low:	3.24 - 3.25	3.25 - 3.27
Close:	3.6 - 3.63	3.63 - 3.65

A U.S.-based firm pivoting from ophthalmic drug-delivery tech (Optejet) to becoming the first Nasdaq-listed U.S. company with a cryptocurrency treasury denominated in HYPE tokens from the Hyperliquid blockchain; also operates a validator (“Kinetiq × Hyperion”) and continues DeFi staking strategies alongside ongoing development of Optejet UFD™ for eye care.

Fri, 27 Mar 2026
Hyperion DeFi, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:HYPD) 2026-03-27 - Seeking Alpha

Fri, 27 Mar 2026
Hyperion DeFi Reports Strong Growth Amid Crypto Volatility - The Globe and Mail

Thu, 26 Mar 2026
Hyperion DeFi Inc (HYPD) Q4 2025 Earnings Call Highlights: Surgi - GuruFocus

Thu, 26 Mar 2026
Hyperion DeFi Reports 4Q and FY 2025 Financial Results with - GlobeNewswire

Thu, 26 Mar 2026
Hyperion DeFi (NASDAQ: HYPD) builds HYPE treasury and targets 4x 2026 profit - Stock Titan

Wed, 25 Mar 2026
Hyperion DeFi, Inc. Q4 earnings preview - MSN

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Devices
Shares Out	-16 (M)
Shares Float	0 (M)
Held by Insiders	8.47e+006 (%)
Held by Institutions	6.9e+006 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	104830
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	-9.4
Profit Margin	0 %
Operating Margin	-3 %
Return on Assets (ttm)	690.9 %
Return on Equity (ttm)	-42.8 %
Qtrly Rev. Growth	813460 %
Gross Profit (p.s.)	183.55
Sales Per Share	122890
EBITDA (p.s.)	-982206
Qtrly Earnings Growth	-1.785e+007 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	-0.39
Price to Sales	0
Price to Cash Flow	0

Dividend	2.05e+006
Forward Dividend	1.89e+006
Dividend Yield	56473800%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.